Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Fangfang Yuan, Weiqiang Xiao, Xiaokun Wang, Yuewen Fu & Xudong Wei. (2023) Clinical Characteristics and Prognosis of Bloodstream Infection with Carbapenem-Resistant Pseudomonas aeruginosa in Patients with Hematologic Malignancies. Infection and Drug Resistance 16, pages 4943-4952.
Read now
Read now
Juan Chen, Qiqiang Liang, Shuo Ding, Yongshan Xu, Yanting Hu, Jingyu Chen & Man Huang. (2023) Ceftazidime/Avibactam for the Treatment of Carbapenem-Resistant Pseudomonas aeruginosa Infection in Lung Transplant Recipients. Infection and Drug Resistance 16, pages 2237-2246.
Read now
Read now
Articles from other publishers (4)
Hai-Hui Zhuang, Ying Chen, Qin Hu, Wen-Ming Long, Xiao-Li Wu, Qin Wang, Tian-Tian Xu, Qiang Qu, Yi-Ping Liu, Yi-Wen Xiao & Jian Qu. (2023) Efficacy and mortality of ceftazidime/avibactam-based regimens in carbapenem-resistant Gram-negative bacteria infections: A retrospective multicenter observational study. Journal of Infection and Public Health 16:6, pages 938-947.
Crossref
Crossref
Hongchen Zhang, Shanshan Hu, Lingyun Li, Hangbin Jin, Jianfeng Yang, Hongzhang Shen & Xiaofeng Zhang. (2023) Development and Assessment of a Novel Predictive Nomogram to Predict the Risk of Secondary CR-GNB Bloodstream Infections among CR-GNB Carriers in the Gastroenterology Department: A Retrospective Case–Control Study. Journal of Clinical Medicine 12:3, pages 804.
Crossref
Crossref
Mikaela M. Walker, Jason A. Roberts, Benjamin A. Rogers, Patrick N. A. Harris & Fekade B. Sime. (2022) Current and Emerging Treatment Options for Multidrug Resistant Escherichia coli Urosepsis: A Review. Antibiotics 11:12, pages 1821.
Crossref
Crossref
Sisi Zhen, Hui Wang & Sizhou Feng. (2022) Update of clinical application in ceftazidime–avibactam for multidrug-resistant Gram-negative bacteria infections. Infection 50:6, pages 1409-1423.
Crossref
Crossref